XERS Competitors & Alternatives

Compare Xeris Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

XERS

Main Stock
$8.74
Tradestie Score
40
Market Cap
$1.29B
Revenue Growth
0.3%
Analyst Upside
+34.0%

Top Competitors

46 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
LQDA Liquidia Corporation Common Stock
$70.27
$1.90B 49.0 59 Compare
TLRY Tilray Brands, Inc. Common Stock
$4.72
$1.84B - 42 Compare
HROW Harrow, Inc. Common Stock
$39.80
$1.79B - 47 Compare
PAHC Phibro Animal Health Corporation Class A
$35.31
$1.65B 15.6 42 Compare
BCRX BioCryst Pharmaceuticals Inc
$9.68
$1.55B - 50 Compare
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
$38.15
$1.49B - 36 Compare
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 48 Compare
EVO Evotec SE American Depositary Shares
$1.89
$1.34B - 35 Compare
ARDX Ardelyx, Inc.
$3.74
$1.29B - 52 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$21.52
$1.25B 12.8 33 Compare

Data updated: Aug 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

46 stocks in this industry